Rafferty Asset Management, LLC Sage Therapeutics, Inc. Transaction History

Rafferty Asset Management, LLC

$26.8 Billion
Q2 2024

A detailed history of Rafferty Asset Management, LLC transactions in Sage Therapeutics, Inc. stock. As of the latest transaction made, Rafferty Asset Management, LLC holds 123,259 shares of SAGE stock, worth $888,697. This represents 0.0% of its overall portfolio holdings.

Number of Shares

123,259

Previous 392,425 68.59%

Holding current value

$888,697

Previous $7.35 Million 81.81%

% of portfolio

0.0%

Previous 0.03%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	SELL	$10.58 - $17.9 $2.85 Million - $4.82 Million	-269,166 Reduced 68.59%	123,259 $1.34 Million
Q1 2024 May 13, 2024	BUY	$18.62 - $26.95 $1.59 Million - $2.3 Million	85,511 Added 27.86%	392,425 $7.35 Million
Q4 2023 Feb 13, 2024	SELL	$17.1 - $22.26 $1.8 Million - $2.34 Million	-104,990 Reduced 25.49%	306,914 $6.65 Million
Q3 2023 Nov 13, 2023	BUY	$16.75 - $48.98 $4.58 Million - $13.4 Million	273,257 Added 197.09%	411,904 $8.48 Million
Q2 2023 Aug 11, 2023	SELL	$40.65 - $59.54 $1.1 Million - $1.61 Million	-27,084 Reduced 16.34%	138,647 $6.52 Million
Q1 2023 May 11, 2023	BUY	$37.27 - $46.57 $69,843 - $87,272	1,874 Added 1.14%	165,731 $6.95 Million
Q4 2022 Feb 13, 2023	SELL	$32.2 - $43.61 $35,291 - $47,796	-1,096 Reduced 0.66%	163,857 $6.25 Million
Q3 2022 Nov 14, 2022	BUY	$32.28 - $43.27 $2.18 Million - $2.92 Million	67,491 Added 69.25%	164,953 $6.46 Million
Q2 2022 Aug 12, 2022	SELL	$27.52 - $37.99 $2.12 Million - $2.93 Million	-77,086 Reduced 44.16%	97,462 $3.15 Million
Q1 2022 May 13, 2022	BUY	$30.71 - $45.71 $1.1 Million - $1.64 Million	35,792 Added 25.79%	174,548 $5.78 Million
Q4 2021 Feb 10, 2022	BUY	$37.06 - $47.11 $2.44 Million - $3.11 Million	65,963 Added 90.62%	138,756 $5.9 Million
Q3 2021 Nov 10, 2021	BUY	$40.26 - $57.37 $1.6 Million - $2.28 Million	39,819 Added 120.76%	72,793 $3.23 Million
Q2 2021 Aug 10, 2021	SELL	$54.88 - $79.29 $513,347 - $741,678	-9,354 Reduced 22.1%	32,974 $1.87 Million
Q1 2021 May 10, 2021	BUY	$70.65 - $96.76 $2.04 Million - $2.79 Million	28,826 Added 213.49%	42,328 $3.17 Million
Q4 2020 Feb 10, 2021	SELL	$58.41 - $89.06 $1.29 Million - $1.97 Million	-22,101 Reduced 62.08%	13,502 $1.17 Million
Q3 2020 Nov 13, 2020	BUY	$41.13 - $62.45 $379,383 - $576,038	9,224 Added 34.97%	35,603 $2.18 Million
Q2 2020 Aug 07, 2020	BUY	$25.95 - $43.15 $684,535 - $1.14 Million	26,379 New	26,379 $1.1 Million
Q1 2020 May 15, 2020	SELL	$26.15 - $77.24 $1.41 Million - $4.16 Million	-53,837 Closed	0 $0
Q4 2019 Feb 10, 2020	BUY	$60.18 - $154.77 $798,949 - $2.05 Million	13,276 Added 32.73%	53,837 $3.89 Million
Q3 2019 Nov 14, 2019	BUY	$140.29 - $189.96 $1.71 Million - $2.32 Million	12,189 Added 42.96%	40,561 $5.69 Million
Q2 2019 Aug 09, 2019	SELL	$157.85 - $183.09 $709,062 - $822,440	-4,492 Reduced 13.67%	28,372 $5.2 Million
Q1 2019 May 15, 2019	BUY	$89.33 - $163.65 $2.94 Million - $5.38 Million	32,864 New	32,864 $5.23 Million

Others Institutions Holding SAGE

# of Institutions

217

Shares Held

48.2M

Call Options Held

854K

Put Options Held

195K

View Full List

About Sage Therapeutics, Inc.

Ticker SAGE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,422,300
Market Cap $428M
Description
Sage Therapeutics, Inc., a biopharmaceutical company, develops and commercializes medicines to treat central nervous system disorders. Its lead product candidate is ZULRESSO, an intravenous formulation of brexanolone for the treatment of postpartum depression (PPD) in adults. The company's product pipeline also includes zuranolone, a neuroactive...

More about SAGE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Rafferty Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Rafferty Asset Management, LLC with notifications on news.

Account

Rafferty Asset Management, LLC Sage Therapeutics, Inc. Transaction History